SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001387131-19-009015
Filing Date
2019-11-25
Accepted
2019-11-25 15:34:52
Documents
1
Group Members
ALTIUM GROWTH FUND, LPALTIUM GROWTH GP, LLC

Document Format Files

Seq Description Document Type Size
1 ACQUISITION OF BENEFICIAL OWNERSHIP tnxp-sc13g_111519.htm SC 13G 167021
  Complete submission text file 0001387131-19-009015.txt   168662
Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Subject) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-86436 | Film No.: 191245953
SIC: 2834 Pharmaceutical Preparations

Mailing Address 551 FIFTH AVE - FL 19 NEW YORK NY 10176
Business Address 551 FIFTH AVE - FL 19 NEW YORK NY 10176 2124842711
Altium Capital Management LP (Filed by) CIK: 0001746382 (see all company filings)

IRS No.: 822066653 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G